Your browser doesn't support javascript.
loading
Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.
Reiter, Florian P; Rau, Monika; Kunzmann, Volker; Kickuth, Ralph; Klein, Ingo; Neumann, Olaf; Stenzinger, Albrecht; Schirmacher, Peter; Geier, Andreas.
Afiliação
  • Reiter FP; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Rau M; Partner site - German Alliance for Liver Cancer (GALC).
  • Kunzmann V; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Kickuth R; Division of Oncology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Klein I; Department of Diagnostic & Interventional Radiology, University Hospital Würzburg, Würzburg, Germany.
  • Neumann O; Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery, University Hospital Würzburg, Würzburg, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Schirmacher P; Partner site - German Alliance for Liver Cancer (GALC).
  • Geier A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Z Gastroenterol ; 61(1): 71-75, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36379463

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Z Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Z Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha